NCT07161869 Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) Status NOT_YET_RECRUITING Phase N/A
NCT07155525 Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas Status RECRUITING Phase PHASE3
NCT07146646 Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer Status RECRUITING Phase PHASE2
NCT07118176 Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Status RECRUITING Phase PHASE1
NCT07106827 A Study of GV20-0251 in Advanced or Refractory Solid Tumors Status RECRUITING Phase PHASE1
NCT07105852 Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT07064447 Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator Status NOT_YET_RECRUITING Phase N/A
NCT07043387 Streamlining Radioembolization for CCC and Metastatic Liver Cancer Status RECRUITING Phase N/A
NCT07030140 Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT07025174 Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE2
NCT06963060 Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06933576 Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working Channel Status COMPLETED Phase N/A
NCT06910670 Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid Status RECRUITING Phase NA
NCT06903273 Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06899854 Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer. Status RECRUITING Phase N/A
NCT06899152 HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer Status RECRUITING Phase NA